Survival differs between countries even for tumours found at the same stage. SURVMARK-2 links the gap to treatment quality, the health system and other illnesses, not just early detection.
Lung Cancer Survival Rate by Country: Japan Leads (2026)
In Japan, 77.8% of lung cancer patients whose tumour is still localised are alive five years later; once it has spread, only 8.2% are.
- No. 1: Japan
- 10 places
01Final list
The leading AIs built their own top-ten lists independently. Above is one combined result that is easy to check: every place has a reason, the AIs that included it and, where the AIs gave one, a source.
Order: from most to least AI agreement.
A bright badge means this AI put the entry on its list. A dim badge means it did not.
- 1
Japan
Top of CONCORD-3, with about one patient in three alive at five years (32.9%). The national registry shows 77.8% survival when the cancer is localised and 8.2% once it has spread.
Included it: Claude, Gemini.In their lists: Claude: 1 · Gemini: 1
What each AI noted 2
- Claudeplace 1
When lung cancer is found while still confined to one organ, 77.8% survive five years; when distant, 8.2%.
Source ↗ - Geminiplace 1
Universal annual health checkups with ubiquitous high-resolution CT imaging catch over 40% of lung tumors in early localized stages, yielding the world's highest net survival.
Source ↗
2 AIs put it here - 2
South Korea
Survival rose from 16.5% (2001-05) to 30.2% (2013-17), and about half of eligible heavy smokers now get CT scans. For later years Gemini cites 36.8%.
Included it: Claude, Gemini.In their lists: Claude: 2 · Gemini: 2
What each AI noted 2
- Claudeplace 2
Roughly half of eligible heavy smokers now get a CT scan, up from 21% when the programme began in 2019.
Source ↗ - Geminiplace 2
Korea's state-run national LDCT screening program for high-risk smokers has catapulted overall five-year survival from 12% in the 1990s to nearly 37% today.
2 AIs put it here - 3
Taiwan
It also screens non-smokers with a family history, and about 85% of the cancers found are stage 0-I (other sources say 95-96.5%). NSCLC survival was still only 23% in 2010-14.
Included it: Claude, Gemini.In their lists: Claude: 3 · Gemini: 3
What each AI noted 2
- Claudeplace 3
Its 2022 national programme also screens non-smokers with a family history, and about 85% of cancers found were stage 0 or I.
Source ↗ - Geminiplace 3
The world's first national screening program to target never-smokers with a family history detects an astounding 85% of screened lung cancers at Stage 0 or I.
2 AIs put it here - 4
United States
67% of NSCLC patients survive five years when the cancer is localised and 12% once it has spread, but only 32% survive overall, because only about 27% are caught at the earliest stage.
Included it: Claude, Gemini.In their lists: Claude: 4 · Gemini: 4
What each AI noted 2
- Claudeplace 4
Localised NSCLC has a 67% five-year survival, but only a third of cases overall survive to five years (32%).
Source ↗ - Geminiplace 4
Early localized detection in the US has reached 27%—a 50% increase over the last decade—driving five-year survival for early-stage lung tumors up to 63%.
Source ↗
2 AIs put it here - 5
Canada
Tied with Norway for the best survival in the seven-country SURVMARK-2 study, and seven provinces offer CT screening in 2026.
Included it: Claude, Gemini.In their lists: Claude: 5 · Gemini: 6
What each AI noted 2
- Claudeplace 5
Along with Norway, it posted the best survival in the seven-country SURVMARK-2 comparison.
Source ↗ - Geminiplace 6
Aggressive provincial rollouts of organized screening programs across Ontario, BC, and Alberta have raised five-year survival to 27%, backed by a median surgery wait of under 3 weeks.
Source ↗
2 AIs put it here - 6
Norway
Level with Canada at the top of SURVMARK-2, and its registry reports 26.2% five-year survival, but no national screening programme figures were found.
Included it: Claude, Gemini.In their lists: Claude: 6 · Gemini: 8
What each AI noted 2
- Claudeplace 6
Level with Canada at the top of SURVMARK-2, and I found no national screening programme figures to add to it.
Source ↗ - Geminiplace 8
Norway's unified Cancer Registry reports that patients catching non-small cell lung cancer at Stage IA achieve an extraordinary five-year relative survival of 84.8%.
Source ↗
2 AIs put it here - 7
Australia
Mid-table in SURVMARK-2, but its national CT programme, launched in July 2025, had 49,473 enrolled by mid-December and nearly 100,000 participants after a year.
Included it: Claude, Gemini.In their lists: Claude: 7 · Gemini: 9
What each AI noted 2
- Claudeplace 7
A national CT screening programme started in July 2025, and nearly 100,000 people had taken part about a year on.
Source ↗ - Geminiplace 9
Australia launched its nationwide targeted National Lung Cancer Screening Program (NLCSP) in 2025, projecting the prevention of over 4,000 lung cancer deaths within a decade.
Source ↗
2 AIs put it here - 8
Israel
One of the higher CONCORD-3 results at 27.0% five-year survival. That is a single-source figure, with no stage or screening data alongside it.
Included it: Gemini. Did not include: Claude.In their lists: Gemini: 5
What each AI noted 1
- Geminiplace 5
With one of the highest CONCORD-3 baseline scores at 27%, Israel pairs rapid diagnostic imaging with universal HMO genetic profiling for targeted therapies.
Source ↗
1 AIs put it here - 9
Switzerland
About 22% five-year survival in CONCORD-3, from one source. Claims about zero waiting times and incidental detection could not be checked.
Included it: Gemini. Did not include: Claude.In their lists: Gemini: 7
What each AI noted 1
- Geminiplace 7
Switzerland achieves one of Europe's lowest mortality-to-incidence ratios by combining zero waiting times for thoracic surgery with broad incidental nodule detection.
1 AIs put it hereno source given - 10
Denmark
Intermediate in SURVMARK-2, between the Canada/Norway leaders and the UK/Ireland tail, and no national screening data were found.
Included it: Claude. Did not include: Gemini.In their lists: Claude: 8
What each AI noted 1
- Claudeplace 8
Mid-table for survival in the seven-country comparison, which suggests treatment is not the whole story.
Source ↗
1 AIs put it here
02Worth knowing
What the AIs noticed while building the list.
Korea's NSCLC survival rose from 16% (2000-04) to 29% (2010-14), before national screening began in 2019, so most of that gain came from other causes.
Taiwan screens never-smokers with a family history. The TALENT cohort found cancer in 2.6% of 12,000 such people, against about 1.1% (NLST) and 0.9% (NELSON) among heavy smokers.
Years matter: CONCORD-3 covers diagnoses from 2010-2014, while national registries now report later cohorts, which is why Korea appears at 25.1%, 30.2% or 36.8% depending on the source.
03Questions people ask
what country has most lung cancer
East Asia carries the largest burden: about 51% of new cases worldwide (1.24 million) and 46.9% of deaths in GLOBOCAN 2022, most of them in China. Hungary has one of the highest rates per person.
Source ↗what percentage of people survive lung cancer
In the US, 32% of NSCLC patients are alive five years after diagnosis. Japan was highest in CONCORD-3 at about 33%, and the weakest systems are under 10%.
Source ↗how likely to survive lung cancer
It depends mostly on stage. Five-year survival is 77.8% for localised cancer and 8.2% for cancer that has spread in Japan, and 67% vs 12% for US NSCLC.
Source ↗how to survive lung cancer
The strongest lever is finding it early, while surgery can still remove it: US survival falls from 67% when localised to 12% once it has spread. That is why Korea, Taiwan and Australia offer CT screening to high-risk people.
Source ↗04How we counted
In plain words, no formulas.
1The question
Top 10 Countries Where Lung Cancer Is Most Often Caught Early and Survived
2Why this topic
Readers see survival, how early cases are found and how far screening reaches in one place, so a country that is strong on one measure and weak on another stands out.
3Where it applies
Global, countries with population-based cancer registries
4What we looked at
- Age-standardised five-year net survival for lung cancer and for non-small cell lung cancer
- Share of cases diagnosed at stage I–II, or the incidence-to-mortality ratio where stage data is missing
- Reach of a national low-dose CT screening programme for high-risk people, and the gap between people eligible and people actually screened
- Time from diagnosis to surgery where it is reported
- CONCORD-3, London School of Hygiene & Tropical Medicine (The Lancet) — Age-standardised five-year net survival for lung cancer from population-based registries, diagnoses 2010-2014
- ICBP SURVMARK-2 (Thorax 2022) — Lung cancer survival by stage, 2010-2014, in seven countries: Australia, Canada, Denmark, Ireland, New Zealand, Norway, UK
- IARC/WHO GLOBOCAN 2022 — New cases and deaths by country; the deaths-to-cases ratio stands in for late detection (global lung ratio 0.71)
- National Cancer Center Japan registry — Net survival by stage, 2012-2015 diagnoses, 44 prefectures
5Who ranked
The leading AIs, each building its own list of ten independently and naming a source for every place: Claude, Gemini.
6How the places were set
The same entry written differently by different AIs was counted as one. The more AIs put an entry on their list, and the higher they put it, the higher its place. "AI agreement" shows how many of the AIs had it on their own list. Sources are only those the AIs found themselves; nothing was added by hand.
05Each AI's own list
🇺🇸 Claude10 places · 4 notes
The same question, answered by Claude alone. The final list above combines all the AIs.
- 1Japan
When lung cancer is found while still confined to one organ, 77.8% survive five years; when distant, 8.2%.
Source ↗ - 2South Korea
Roughly half of eligible heavy smokers now get a CT scan, up from 21% when the programme began in 2019.
Source ↗ - 3Taiwan
Its 2022 national programme also screens non-smokers with a family history, and about 85% of cancers found were stage 0 or I.
Source ↗ - 4United States
Localised NSCLC has a 67% five-year survival, but only a third of cases overall survive to five years (32%).
Source ↗ - 5Canada
Along with Norway, it posted the best survival in the seven-country SURVMARK-2 comparison.
Source ↗ - 6Norway
Level with Canada at the top of SURVMARK-2, and I found no national screening programme figures to add to it.
Source ↗ - 7Australia
A national CT screening programme started in July 2025, and nearly 100,000 people had taken part about a year on.
Source ↗ - 8Denmark
Mid-table for survival in the seven-country comparison, which suggests treatment is not the whole story.
Source ↗ - 9United Kingdom
The lowest tier of SURVMARK-2, where the survival gap persisted even within the same stage.
Source ↗ - 10Ireland
Also in the lowest SURVMARK-2 group, with no national screening programme data found.
Source ↗
What Claude noticed
The same disease, found at the same stage, is survived differently by country. SURVMARK-2 found survival differences within stages, pointing to treatment quality and comorbidity as well as early detection.
Korea's NSCLC survival rose from 16% (2000-2004) to 29% (2010-2014) before its national screening began in 2019, so most of that gain came from other causes.
Taiwan screens non-smokers with a family history. The TALENT research cohort found cancer in 2.6% of 12,000 never-smokers with risk factors, against about 1.1% in NLST and 0.9% in NELSON for heavy smokers.
Pope Leo XIV's cancer was caught on a routine check and removed surgically, the kind of early-stage route where Japan reports 77.8% five-year survival when localised.
🇺🇸 Gemini10 places · 2 notes
The same question, answered by Gemini alone. The final list above combines all the AIs.
- 1Japan
Universal annual health checkups with ubiquitous high-resolution CT imaging catch over 40% of lung tumors in early localized stages, yielding the world's highest net survival.
Source ↗ - 2South Korea
Korea's state-run national LDCT screening program for high-risk smokers has catapulted overall five-year survival from 12% in the 1990s to nearly 37% today.
- 3Taiwan
The world's first national screening program to target never-smokers with a family history detects an astounding 85% of screened lung cancers at Stage 0 or I.
- 4United States
Early localized detection in the US has reached 27%—a 50% increase over the last decade—driving five-year survival for early-stage lung tumors up to 63%.
Source ↗ - 5Israel
With one of the highest CONCORD-3 baseline scores at 27%, Israel pairs rapid diagnostic imaging with universal HMO genetic profiling for targeted therapies.
Source ↗ - 6Canada
Aggressive provincial rollouts of organized screening programs across Ontario, BC, and Alberta have raised five-year survival to 27%, backed by a median surgery wait of under 3 weeks.
Source ↗ - 7Switzerland
Switzerland achieves one of Europe's lowest mortality-to-incidence ratios by combining zero waiting times for thoracic surgery with broad incidental nodule detection.
- 8Norway
Norway's unified Cancer Registry reports that patients catching non-small cell lung cancer at Stage IA achieve an extraordinary five-year relative survival of 84.8%.
Source ↗ - 9Australia
Australia launched its nationwide targeted National Lung Cancer Screening Program (NLCSP) in 2025, projecting the prevention of over 4,000 lung cancer deaths within a decade.
Source ↗ - 10Sweden
Centralized thoracic surgical units ensure that 74% of Swedish lung cancer patients diagnosed in Stage I receive immediate minimally invasive video-assisted resection.
Source ↗
What Gemini noticed
Catching lung cancer at Stage I yields an average five-year survival rate between 60% and 85%, whereas waiting until symptoms prompt diagnosis at Stage IV plummets survival to just 3% to 10%.
Despite low-dose CT screening being proven to reduce lung cancer mortality by 20% in the National Lung Screening Trial (NLST), fewer than 6% of eligible high-risk Americans actually undergo annual screening.